These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34800610)

  • 1. Gut-derived systemic inflammation as a driver of depression in chronic liver disease.
    Kronsten VT; Tranah TH; Pariante C; Shawcross DL
    J Hepatol; 2022 Mar; 76(3):665-680. PubMed ID: 34800610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbiota in cirrhosis and its role in hepatic decompensation.
    Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
    J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
    Trebicka J; Bork P; Krag A; Arumugam M
    Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):167-180. PubMed ID: 33257833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Major depression and liver disease: the role of microbiome and inflammation].
    Kahl KG; Krüger T; Eckermann G; Wedemeyer H
    Fortschr Neurol Psychiatr; 2019 Feb; 87(1):12-21. PubMed ID: 29490382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.
    Chen D; Le TH; Shahidipour H; Read SA; Ahlenstiel G
    Cells; 2019 Oct; 8(11):. PubMed ID: 31717860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis.
    Riva A; Gray EH; Azarian S; Zamalloa A; McPhail MJW; Vincent RP; Williams R; Chokshi S; Patel VC; Edwards LA
    JHEP Rep; 2020 Dec; 2(6):100151. PubMed ID: 32838247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation?
    Kronsten VT; Shawcross DL
    Anal Biochem; 2022 Jan; 636():114437. PubMed ID: 34715068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver cirrhosis and immune dysfunction.
    Hasa E; Hartmann P; Schnabl B
    Int Immunol; 2022 Sep; 34(9):455-466. PubMed ID: 35792761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
    Acharya C; Sahingur SE; Bajaj JS
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut-Liver Axis in Cholestatic Liver Diseases.
    Blesl A; Stadlbauer V
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging.
    Mou Y; Du Y; Zhou L; Yue J; Hu X; Liu Y; Chen S; Lin X; Zhang G; Xiao H; Dong B
    Front Immunol; 2022; 13():796288. PubMed ID: 35464431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut-liver-immune axis to treat cirrhosis.
    Tranah TH; Edwards LA; Schnabl B; Shawcross DL
    Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.